Merck wins Indian injunction against Januvia copycats

Merck's ($MRK) Indian unit won an injunction in a patent fight over its diabetes drugs Januvia and Janumet, blocking generic versions of the two drugs to be made by Indian drugmaker Aprica Pharmaceuticals. It's one of the few recent patent court decisions there in favor of Big Pharma. Report